COVID-19 mRNA Vaccine(Cnbg-Virogin)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameCOVID-19 mRNA Vaccine(Cnbg-Virogin)
Drug Alias NameZSVG-02-O
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionCoronavirus spike glycoprotein inhibitorsImmunostimulants
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCnbg-Virogin Biotech (Shanghai) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCnbg-Virogin Biotech (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A